Xiying Shao
- Cancer Research top 10%
- Breast Cancer Treatment Studies 16
- Cancer Genomics and Diagnostics 5
-
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 15
- Cancer-related Molecular Pathways 5
-
- Advanced Breast Cancer Therapies 18
-
- Estrogen and related hormone effects 6
- Chronic Lymphocytic Leukemia Research 4
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (8 papers)
- Partner nations
- ChinaUnited StatesSouth Africa
In The Last Decade
Xiying Shao
53 papers receiving 460 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 189
- Oncology 184
- Immunology 108
- Pulmonary and Respiratory Medicine 85
- Molecular Biology 172
Countries citing papers authored by Xiying Shao
This map shows the geographic impact of Xiying Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiying Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiying Shao more than expected).
Fields of papers citing papers by Xiying Shao
This network shows the impact of papers produced by Xiying Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiying Shao. The network helps show where Xiying Shao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiying Shao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 0 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 16 | |
| 15 | 2020 | 10 | |
| 16 | 2019 | 25 | |
| 17 | 2016 | 7 | |
| 18 | 2015 | 101 | |
| 19 | Outcome prediction values of soluble human epidermal growth factor receptor-2 extracellular domain in metastatic breast cancer. | 2014 | 6 |
| 20 | Inhibition of the Growth of Human Breast Cancer Cell Line Bcap-37 with Matrine | 2012 | 2 |
About Xiying Shao
Xiying Shao is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 60 papers that have together received 462 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (18 papers), Cancer Treatment and Pharmacology (17 papers), Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (15 papers), Estrogen and related hormone effects (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Cancer Research (189 citations), Oncology (184 citations) and Immunology (108 citations). Xiying Shao has collaborated with scholars based in China, United States and South Africa. Frequent co-authors include Xiaojia Wang, Zhanhong Chen, Yabing Zheng, Yu‐An Huang, Xiaojia Wang, Wen‐Ming Cao, Ping Huang, Jian Huang, Lei Shi and Chenyang Qiu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.